Literature DB >> 22303018

Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Eric L Brown1, Yasuhiro Nishiyama, Jesse W Dunkle, Shreya Aggarwal, Stephanie Planque, Kenji Watanabe, Keri Csencsits-Smith, M Gabriela Bowden, Sheldon L Kaplan, Sudhir Paul.   

Abstract

Antibodies that recognize microbial B lymphocyte superantigenic epitopes are produced constitutively with no requirement for adaptive immune maturation. We report cleavage of the Staphylococcus aureus virulence factor extracellular fibrinogen-binding protein (Efb) by catalytic antibodies produced with no exposure to the bacterium and reduction of the catalytic antibody activity following infection. IgG catalytic antibodies that specifically hydrolyzed Efb via a nucleophilic catalytic mechanism were found in the blood of healthy humans and aseptic mice free of S. aureus infection. IgG hydrolyzed peptide bonds on the C-terminal side of basic amino acids, including a bond located within the C3b-binding domain of Efb. Efb digested with the IgG lost its ability to bind C3b and inhibit complement-dependent antibody-mediated red blood cell lysis. In addition to catalysis, the IgG expressed saturable Efb binding activity. IgG from S. aureus-infected mice displayed reduced Efb cleaving activity and increased Efb binding activity compared with uninfected controls, suggesting differing effects of the infection on the antibody subsets responsible for the two activities. IgG from children hospitalized for S. aureus infection also displayed reduced Efb cleavage compared with healthy children. These data suggest a potential defense function for constitutively produced catalytic antibodies to a putative superantigenic site of Efb, but an adaptive catalytic response appears to be proscribed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22303018      PMCID: PMC3323049          DOI: 10.1074/jbc.M111.330043

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  Solution structure of the catalytic domain of gammadelta resolvase. Implications for the mechanism of catalysis.

Authors:  B Pan; M W Maciejewski; A Marintchev; G P Mullen
Journal:  J Mol Biol       Date:  2001-07-27       Impact factor: 5.469

Review 2.  Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.

Authors:  Sudhir Paul; Stephanie Planque; Yasuhiro Nishiyama
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

3.  High levels of catalytic antibodies correlate with favorable outcome in sepsis.

Authors:  Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri; David Hayon-Sonsino; Nithyananda Thorenoor; Julien Charpentier; Charles-Edouard Luyt; Jean-Paul Mira; Valakunja Nagaraja; Michel D Kazatchkine; Jean-François Dhainaut; Vincent O Mallet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 4.  Staphylococcal innate immune evasion.

Authors:  Suzan H M Rooijakkers; Kok P M van Kessel; Jos A G van Strijp
Journal:  Trends Microbiol       Date:  2005-10-19       Impact factor: 17.079

Review 5.  Confounding B-cell defences: lessons from a staphylococcal superantigen.

Authors:  Gregg J Silverman; Carl S Goodyear
Journal:  Nat Rev Immunol       Date:  2006-06       Impact factor: 53.106

6.  PIGS: automatic prediction of antibody structures.

Authors:  Paolo Marcatili; Alessandra Rosi; Anna Tramontano
Journal:  Bioinformatics       Date:  2008-07-19       Impact factor: 6.937

Review 7.  Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Michael Otto
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

8.  Site-directed mutagenesis of proteolytic antibody light chain.

Authors:  Q S Gao; M Sun; A R Rees; S Paul
Journal:  J Mol Biol       Date:  1995-11-10       Impact factor: 5.469

9.  Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.

Authors:  Simon R Clarke; Kirsten J Brummell; Malcolm J Horsburgh; Philip W McDowell; Sharifah A Syed Mohamad; Melanie R Stapleton; Jorge Acevedo; Robert C Read; Nicholas P J Day; Sharon J Peacock; James J Mond; John F Kokai-Kun; Simon J Foster
Journal:  J Infect Dis       Date:  2006-03-13       Impact factor: 5.226

10.  Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G).

Authors:  C B Morris; E Cheng; A Thanawastien; L Cárdenas-Freytag; J D Clements
Journal:  Vaccine       Date:  2000-03-17       Impact factor: 3.641

View more
  6 in total

1.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

Review 2.  Antibody-Mediated Catalysis in Infection and Immunity.

Authors:  Anthony Bowen; Maggie Wear; Arturo Casadevall
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

3.  Physiological IgM class catalytic antibodies selective for transthyretin amyloid.

Authors:  Stephanie A Planque; Yasuhiro Nishiyama; Mariko Hara; Sari Sonoda; Sarah K Murphy; Kenji Watanabe; Yukie Mitsuda; Eric L Brown; Richard J Massey; Stanley R Primmer; Brian O'Nuallain; Sudhir Paul
Journal:  J Biol Chem       Date:  2014-03-19       Impact factor: 5.157

Review 4.  Catalytic Antibodies: Design, Expression, and Their Applications in Medicine.

Authors:  Daqun Zhao; Jie Chen; Xiaoyue Hu; Shujun Zhang
Journal:  Appl Biochem Biotechnol       Date:  2022-10-12       Impact factor: 3.094

5.  Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24.

Authors:  Sarah M Gunter; Kathryn M Jones; Bin Zhan; Heather T Essigmann; Kristy O Murray; Melissa N Garcia; Rodion Gorchakov; Maria Elena Bottazzi; Peter J Hotez; Eric L Brown
Journal:  Am J Trop Med Hyg       Date:  2015-11-23       Impact factor: 2.345

6.  Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States.

Authors:  Evgeny A Ermakov; Georgy A Nevinsky; Valentina N Buneva
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.